The BCBS decision pertains to gadopiclenol, a gadolinium-based product sold under the brand names Elucirem and Vueway. 

Radiology Business sat down with Akumin’s new CEO, Krishna Kumar, MBA, who took over the role in February, the same month the organization emerged from Chapter 11. 

The Food and Drug Administration approval comes amid growing interest in remote-scan technology following the COVID pandemic. 

The college has drafted a position statement related to this hot topic, outlining “high-level principles that form the basis for more specific ACR guidance to come.” 

RadNet Inc. presented new research at RSNA 2024, showing that women who paid $40 for an AI add-on experienced a 21% higher breast cancer detection rate.